Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

JOURNAL ARTICLE published 1 March 2013 in Journal of Clinical Oncology

Authors: Sherene Loi | Nicolas Sirtaine | Fanny Piette | Roberto Salgado | Giuseppe Viale | Françoise Van Eenoo | Ghizlane Rouas | Prudence Francis | John P.A. Crown | Erika Hitre | Evandro de Azambuja | Emmanuel Quinaux | Angelo Di Leo | Stefan Michiels | Martine J. Piccart | Christos Sotiriou